Skip to main content
Log in

Should Patients with Implantable Cardioverter-Defibrillators Be Allowed to Drive? Observations in 291 Patients from a Single Center over an 11-year Period

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Motor-vehicle driving restrictions for patients with implantable cardioverter-defibrillators (ICDs) vary widely throughout the world because safety concerns have never been adequately resolved in this patient population. To address this issue, we examined the driving behavior of 291 ICD patients to correlate the frequency of device therapy during driving, the occurrence of syncopal symptoms, and the incidence of traffic accidents. Fifty of the 291 patients had never driven. Of the remaining 241 patients, 171 (59%) continued driving postimplant and 70 (24%) elected to stop prior to (n = 30) or at the time of ICD implantation (n = 40). Patients were followed for a mean of 38 ± 26 months (range <1–124). During this period, no patients died while driving. Of 11 accidents involving 11 driving patients (6%), only 1 was caused by the driver, and none was related to syncopal symptoms or ICD therapy. Although 2 accidents (8%) occurred within 12 months postimplant, the majority (50%) took place after more than 36 months. ICD therapy was delivered in 8 patients (5%) while driving: 13% (1 episode) of the discharges occurred within the first year postimplant, 13% (1 episode) occurred between 1–2 years, and 74% (6 episodes) occurred >2 years. None of these patients experienced syncope before or during these episodes. A multivariate analysis was unable to identify any variables that might predict increased risk of ICD therapy (with or without sudden death) while driving and consequent motor vehicle accidents. Our data suggest that such events occur only rarely

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jimenez A, Myerburg RJ. Sudden cardiac death: Magnitude of the problem, substrate/trigger interaction, and populations at high risk. In: Akhtar M, ed. Cardiology Clinics. Philadelphia: WB Saunders, 1993, pp. 1-9.

    Google Scholar 

  2. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.

    Google Scholar 

  3. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-233.

    Google Scholar 

  4. Trappe HJ, Pfitzner P, Fieguth HG, Wenzlaff P, Kielblock B, Klein H. Nonpharmacological therapy of ventricular tachyarrhythmias: Observations in 554 patients. PACE 1994; 17(Part II):2172-2177.

    Google Scholar 

  5. Nisam S, Kaye SA, Mower MM, Hull M. AICD automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients. PACE Pacing Clin Electrophysiol 1995;18 (Part II):142-147.

    Google Scholar 

  6. Anderson MH, Camm AJ. Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator. Am Heart J 1994;127:1185-1193.

    Google Scholar 

  7. Trappe HJ, Klein H, Kielblock B. Role of antitachycardia pacing in patients with third generation cardioverter defibibrillators. PACE 1994;17:506-513.

    Google Scholar 

  8. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. The Wadsworth Statistical Probability Series 1984.

  9. Curtis AB, Conti JB, Tucker KJ, Kubilis PS, Reilly RE, Woodard DA. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator. J Am Coll Cardiol 1995;26:180-184.

    Google Scholar 

  10. Consensus Conference, Canadian Cardiovascular Society. Assessment of the cardiac patient for fitness to drive. Can J Cardiol 1992;8:406-411.

    Google Scholar 

  11. Reiter MJ, Fain ES, Senelly KM. Determinants of recurrent ventricular arrhythmias in patients with implantable pacemaker/defibrillators. Circulation 1991;84 (Suppl. II):426 (Abstract).

    Google Scholar 

  12. Levine JH, Mellits D, Baumgardner RA, Veltri EP, Mower M, Grunwald L, Guarnieri T, Aarons D, Griffith LSC. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter defibrillators. Circulation 1991;84:558-566.

    Google Scholar 

  13. Anderson M, Poloniecki J, Stein T, Ward DE, Rowland E, Camm AJ. Ejection fraction alone predicts recurrence of arrhythmias in implantable cardioverter defibrillator patients. Eur Heart J 1993;14(Suppl.):167 (Abstract).

    Google Scholar 

  14. Kou WH, Calkins H, Lewis RR, Bolling SF, Kirsch MM, Langberg JJ, de Buitleir M, Sousa J, El-Atassi R, Morady F. Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks. Ann Intern Med 1991; 115:942-945.

    Google Scholar 

  15. Keelan ET, Dhala A, Sra J, Axtell K, Maglio C, Jazzayeri MR, Blanck Z, Deshpande S, Biehl M, Akhtar M. Driving safety in patients with implantable cardioverter-defibrillators: A single center experience. J Am Coll Cardiol 1995; 145A (Abstract).

  16. Zilo P, Luceri RM, Vardeman LL. Driving after implantation of a cardioverter-defibrillator. PACE Pacing Clin Electrophysiol 1994;17(Part II):781 (Abstract).

    Google Scholar 

  17. Jenkins LS, Davis PG, Dunbar SB, Hawthorne MH, Porter L. Driving behavior and device firings reported by patients 1,3 & 6 months post implantation. PACE Pacing Clin Electrophysiol 1995;18 (Part II):945.

    Google Scholar 

  18. Finch NJ, Leman RB, Kratz JM, Gillette PC. Driving safety among patients with automatic implantable cardioverter defibrillator. JAMA 1993;270:1587-1588.

    Google Scholar 

  19. Larsen GC, Stupey MR, Walance CG, Griffith KK, Cutler JE, Kron J, McAnulty JH. Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia: Implications for driving restrictions. JAMA 1994;271:1335-1339.

    Google Scholar 

  20. Tucker KJ, Conti JB, King LC, Reilly RE, Curtis AB. Driving behavior after implantation of cardioverter-defibrillators. PACE Pacing Clin Electrophysiol 1994; 17(Part II): 781 (Abstract).

    Google Scholar 

  21. Myerburg RJ, Davis JH. The medical ecology of public safety. I: Sudden death due to coronary heart disease. Am Heart J 1964; 68:586-595.

    Google Scholar 

  22. Bowen DA. Deaths of drivers of automobiles due to trauma and ischemic heart disease, a survey and assessment. Forensic Sci 1973; 2:285-290.

    Google Scholar 

  23. DiCarlo LA, Winston SA, Honoway S, Reed P. Driving restrictions advised by midwestern cardiologists implanting cardioverter defibrillators: Present practices, criteria utilized, and compatibility with existing state laws. PACE Pacing Clin Electrophysiol 1992;15:1131-1136.

    Google Scholar 

  24. Jung W, Anderson M, Camm AJ, Joetdans L, Petch MC, Rosenqvist M, Santini M, Luederitz B, on behalf of the Study Group on “ICD and Driving” of the working groups on cardiac pacing and arrhythmias of the European Society of Cardiology. Eur Heart J 1997;18:1210-1219.

    Google Scholar 

  25. Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PL, Garson A Jr, Harvey JC, Kidwell GA, Klein GJ, Levine PA, Marchlinski FE, Prystowsky EN, Wilkoff BL. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation 1996;94:1147-1166.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trappe, HJ., Wenzlaff, P. & Grellman, G. Should Patients with Implantable Cardioverter-Defibrillators Be Allowed to Drive? Observations in 291 Patients from a Single Center over an 11-year Period . J Interv Card Electrophysiol 2, 193–201 (1998). https://doi.org/10.1023/A:1009763818159

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009763818159

Navigation